(E)-3-(5-Morpholin-4-yl-2-nitrophenyl)acrylic acid, 95.0%, 500mg

Ethyl 6-bromo-1H-pyrrolo[3,2-b]pyridine-3-carboxylate, 97%, 1g

(S)-3-Amino-3-(4-chlorophenyl)-2,2-difluoropropionic acid hydrochloride, 97.0%, 250mg

2,5-Dimethylfuran-3-carboxylic acid, 95.0%, 10g

ALISKIREN HEMIFUMARATE, 95%, 1g

1-Cyclohexyl-3-mesityl-1H-imidazol-3-ium chloride, 97%, 250mg

Methyl 2-(chloromethyl)isonicotinate hydrochloride, 98%, 250mg

3-Fluoro-2-iodochlorobenzene, 95.0%, 500g

Recipiente de evaporación ROTILABO® forma alta, 250 ml, 1 Pieza

5-bromo-4-methyl-1H-1,2,3-triazole, 97, 250mg

Diethyl 2,3-diacetylsuccinate, 50g

Sodium DL-2-Hydroxybutyrate>98.0%(T)25g

Quinoline-3-sulfonyl chloride, 95.0%, 100mg